Christopher Walpole
AstraZeneca (Poland)(PL)AstraZeneca (Canada)(CA)
Publications by Year
Research Areas
Pharmacological Receptor Mechanisms and Effects, Neuropeptides and Animal Physiology, Pain Mechanisms and Treatments, Ion Channels and Receptors, Cannabis and Cannabinoid Research
Most-Cited Works
- → Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin(1992)582 cited
- → The Discovery of Capsazepine, the First Competitive Antagonist of the Sensory Neuron Excitants Capsaicin and Resiniferatoxin(1994)209 cited
- → Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 1. The aromatic "A-region"(1993)162 cited
- → New Diarylmethylpiperazines as Potent and Selective Nonpeptidic δ Opioid Receptor Agonists with Increased In Vitro Metabolic Stability(2000)115 cited
- → Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 3. The hydrophobic side-chain "C-region"(1993)110 cited
- → Similarities and Differences in the Structure−Activity Relationships of Capsaicin and Resiniferatoxin Analogues(1996)93 cited
- → Analogs of capsaicin with agonist activity as novel analgesic agents; structure-activity studies. 2. The amide bond "B-region"(1993)83 cited
- → A comparison of capsazepine and ruthenium red as capsaicin antagonists in the rat isolated urinary bladder and vas deferens(1993)79 cited
- → Novel benzimidazole derivatives as selective CB2 agonists(2008)66 cited
- → 2-Nitrophenylcarbamoyl-(S)-prolyl-(S)-3-(2-naphthyl)alanyl-N-benzyl-N- methylamide (SDZ NKT 343), a Potent Human NK1 Tachykinin Receptor Antagonist with Good Oral Analgesic Activity in Chronic Pain Models(1998)65 cited